Argo Blockchain raises cash to reduce debt

0

Argo Blockchain (LON: ARB) is the worst Main Market performer following the placing and PrimaryBid offer. This raised £5.7m at 10p/share and the market price slumped 19.6% to 10.85p.

The cash raised will help to reduce the debt of the cryptocurrency miner and thereby cut the interest charge. Debt was £59.1m, including a £25m asset-backed loan from Galaxy Digital and £31.4m of senior unsecured notes. Galaxy Digital acquired the Helios facility from the company at the end of last year.

Argo Blockchain is also evaluating opportunities with power generators to help capture the full economic value of stranded or underutilised energy.

In June, 139 Bitcoin were mined, which was lower than the previous month because of the curtailment of mining activities at the Helios facility. There should be additional cash proceeds from power trading activities by the operator of Helios.

At the end of June, Argo Blockchain held 44 Bitcoin. New BlockMiner machines are being installed at the Quebec facilities. This will increase total hashrate capacity to approximately 2.8EH/second.

AIM movers: OptiBiotix Health soars on SweetBiotix news and Watkin Jones warning

0

OptiBiotix Health (LON: OPTI) updated the market on its SweetBiotix sweeteners products, which do not have the health concerns of rival sweeteners. They have a low glycemic index and enhance the gut microbiome. Manufacturing is being scaled up and product is being tested for consistency and shelf life. OptiBiotix Health says that well-known consumer brands like Kellogg’s, Nestle and Coca Cola are interested in SweetBiotix. These multinational brands would not allow themselves to be mentioned if they were not strongly considering the use of SweetBiotix. The share price jumped 59.9% to 11.75p. This is the highest the share price has been since March.

Audio visual services provider MediaZest (LON: MDZ) says trading in the Netherlands has started and more than €500,000 of orders have been received. New projects have also been won in the UK. Management is confident that it will report improved results for the year to September 2023. The share price moved ahead by 16.7% to 0.0525p.

Cornish Metals (LON: CUSN) has installed a second submersible pump at the South Crofty tin mine and this will reduce the water level in the mine. The mine water treatment plant should start up in August. Results are expected from drilling in the North Pool zone and the Dolcoath lodes. The share price is 13.8% higher at 13.375p.

Ariana Resources (LON: AAU) says the local authorities have approved the recommencement of construction activities at the Tavsan mine site. This is part of the Zenit Madenilik San joint venture where Ariana Resources has a 23.5% stake. Large scale, open pit mining operations should commence in the first half of 2024. The share price rose 12.8% to 2.425p.

Defence equipment and services provider Cohort (LON: CHRT) increased full year revenues by one-third to £182.7m. There was a 17% increase in earnings to 36.5p/share. The dividend is 10% higher at 13.4p/share. The order book is worth £329m. Both divisions improved their performance. The share price rose 9.35% to 14.625p.

Faron Pharmaceuticals (LON: FARN) revealed clinical data from the ongoing Phase I/II BEXMAB study for the treatment of aggressive hematological malignancies of relapsed/refractory (r/r) acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The Phase I results indicate encouraging efficacy and long duration of the responses. Faron Pharmaceuticals is seeking FDA advice and expects to move to Phase II of the study in the second half of 2023. The share price increased 9.09% to 276p.

FALLERS

The timing of transactions remains a concern for Watkin Jones (LON: WJG) and full year profit will be lower than expected even before impairment charges. Institutional investment in student accommodation and build-to-rent properties has slowed. Transactions that were expected to be completed by September may fall into next year. Non-core assets may be sold and that is why there is a £10m impairment charge. Watkin Jones was forecast to make a pre-tax profit of £25.1m this year, but this has been downgraded to breakeven. There could also be a £35m provision for remedial work on past properties. Chief executive Richard Simpson has stepped down. The share price slumped 38.8% to 47.25p.

Revolution Beauty (LON: REVB) has confirmed the withdrawal of general meeting requisition by boohoo (LON: BOO). Bob Holt and Derek Zissman have left the board, but Elizabeth Lake will remain as finance director – boohoo was trying to remove her. Alistair McGeorge (as executive chairman), Neil Catto, Rachel Horsefield and Peter Hallett. That takes the number of board members to eight. Bob Holt, who will continue to run the business until the end of August, and Elizabeth Lake have exercised options. Bob Holt acquired 5.68 million shares and sold 2.56 million to boohoo, while Elizabeth Lake bought exercised 2.84 million options and sold 1.34 million to boohoo – the selling price is 32.625p/share. The market price fell 173% to 31.25p. The audit of the 2022-23 results should be achieved by the end of August. The boohoo share price rose 4.3% to 36.505p.

OptiBiotix Health jumps on new sweetener product development

OptiBiotix Health shares were firmly higher on Wednesday after announcing the development of a new sweetener product.

OptiBiotix has developed a portfolio of patented, zero or low-calorie sweet dietary fibres, called SweetBiotix® which avoids the health concerns associated with sugars and syrups.

OptiBiotix Health shares were around 29% at 9.30am on Wednesday.

The new products will target a sugar substitutes market estimated to be worth $18.8 billion in 2023 and forecast to grow to $24.3 billion by 2028.

The new product will have a broad range of applications including fizzy drinks, snacks, bakery products, dairy products and cereals.

“The development of a unique product concept within an industry is high risk, particularly in the food industry where you are competing in an industry dominated by a small number of large global players with demanding requirements,” said Stephen O’Hara, CEO of OptiBiotix.

“OptiBiotix has looked to overcome these challenges by working closely with partners during the product development process and believes it has created a product portfolio of sweet prebiotic fibres, called SweetBiotix®, which meet a large and growing unmet industry and consumer need. SweetBiotix® are unique in being classified as dietary fibres creating the opportunity to replace unhealthy calorific and cariogenic sugars with healthy fibres in a wide range of food and beverage products or as an ingredient in its own right.”

“With growing industry and consumer health concerns over traditional sugars and sweeteners, the approaching commercialisation of the SweetBiotix® family of products offers shareholders the potential for a significant enhancement in the value of the Company.”

Watkin Jones shares crumble on impairment charge and stagnant profits

Watkin Jones shares were in free fall on Wednesday after the build-to-rent and student accommodation company said remedial work and slow market conditions would impact earnings.

Watkin Jones shares were down around 36% at the time of writing.

The company announced it may fail to complete targeted forward sales deals by fiscal year-end due to rising interest rates and low market liquidity. Watkin Jones also plans to take a £10 million impairment charge on certain assets given the increased cost of funding and macro-economic backdrop.

With property sales stalled, Watkin Jones said it likely won’t materially improve on its £2 million underlying pre-tax profit recorded in the first half of the year. For fiscal 2024, it forecasts a profit before tax of £15-20 million.

Adding to its woes, Watkin Jones aims to boost provisions for remedial work on legacy properties by £30-35 million, spread over five years. This follows its decision to sign the UK government’s Responsible Actors Scheme to reimburse funds for rectifying safety issues in residential buildings.

Its net cash position is £36 million and the company says its balance sheet will allow for a degree of agility going forward.

FTSE 100 surges as UK inflation cools; GBP/USD falls

The FTSE 100 surged on Wednesday as stocks reacted to news UK CPI fell to 7.9% in June.

London’s leading index jumped 1.70% to 7,580 as of 14.00pm on Wednesday.

The lower-than-expected 7.9% CPI inflation reading suggests the Bank of England may have room to slow down the pace of their rate hikes during the rest of 2023. Economists had predicted CPI would fall to 8.2% from 8.7%.

“Today’s year-on-year UK inflation print of 7.9% is a step in the right direction and evidence that the significant financial medicine in the form of interest rate hikes is taking effect. The big number of 7.9% is still well off the ‘no ifs or buts’ 2% target, and the cost of living crisis remains painfully evident,” said Saxo UK CEO, Charles White-Thomson.

“With this in mind, we should prepare for a 25bp hike by the Bank of England on August 03. The war to defeat inflation is not over and the Governor has nailed his colours to the 2% target.”

Housebuilders jump

As we wrote yesterday, there would likely be sharp moves in housebuilders on the open today should inflation deviate from economist expectations.

Indeed, the lower-than-expected inflation reading sparked a rally in housebuilders, with Persimmon up over 8% in early trade. Barratt Developments rose around 7%, and Taylor Wimpey added over 6%.

“Investors are taking the view that if inflation is on a sustained downward path, then the Bank of England might be less eager to keep pushing up interest rates. The market is desperate for that pivot moment where central banks call the end to the current rate rise cycle,” said Danni Hewson, head of financial analysis at AJ Bell.

Real Estate Investment Trusts were getting in on the action with Land Securities rising 8%. Rightmove jumped 6%.

GBP/USD

The prospect of diverging inflation rates could have set the Bank of England and the Federal Reserve on different monetary policy paths for the rest of 2023. Today’s data will allow the Bank of England to pause interest rate hikes later in the year should inflation continue to fall.

This would bring the BoE back in line with the Fed and makes the recent rally in GBP/USD look overdone.

GBP/USD was down 0.6% to 1.2951 at the time of writing. The weaker pound was providing support for the FTSE 100’s overseas earners.

“The inflation reading has dampened the outlook for interest rate hikes in the UK, much to the excitement of investors,” Danni Hewson said.

FTSE 100 flat as Ocado soars, UK inflation data awaited

London’s leading index did little to inspire investors on Tuesday, with attention firmly fixed on US bank earnings and tomorrow’s UK inflation data.

The FTSE 100 was up 3 points to 7,409 at 14.00 on Tuesday.

“After a decent showing on Wall Street last night, European markets were less enthusiastic with most of the major indices struggling to find direction,” said Danni Hewson, head of financial analysis at AJ Bell.

UK markets will be looking forward to the release of June’s UK inflation reading set for release tomorrow morning. Economists forecast the UK CPI inflation rate to fall to 8.2% in June from 8.7% in May.

There is a divergence in inflation rates in major global economies, and tomorrow’s reading will have implications for FX markets and the FTSE 100.

Ocado

Ocado was the standout FTSE 100 performed on Tuesday as the food retailer and technology company soared 16% after releasing a reasonably upbeat half-year report.

Group revenue grew 9% to £1.4bn as their technology solutions revenue surged 59%. After reporting an EBITDA loss in 2022, Ocado produced £16.6m EBITDA in the first half of 2023. This evidently pleased investors and worried Ocado’s short sellers.

“There are two ways of looking at Ocado’s results. The business has generated a small EBITDA profit versus market forecasts of a loss. Sales are up across all of its divisions and clients are busy opening new fulfilment centres or reaping the benefits of Ocado’s system through improved operational performance. Ocado even believes it could win contracts outside of the grocery sector for its technology,” said Danni Hewson.

“However, a bear would point to ongoing pre-tax losses for the group, continued slow pace in signing up new partners, and pedestrian gains in the total number of active customers for its UK retail operations.

“That life isn’t getting any worse for the company is enough to satisfy the market. Although what matters to most investors is whether Ocado remains a takeover target. Rumours that Amazon wanted to buy the business breathed new life into the share price in recent weeks but the retail giant has remained quiet on the speculation.”

FTSE 100 movers

Housebuilders were among the top risers ahead of tomorrow’s UK inflation data. If inflation falls more than expected, it lessens the need for further interest rate hikes – something housebuilders desperately need.

Persimmon, Taylor Wimpey and Barratt Developments were 4%-5% higher at the time of writing. Expect sharp moves in the sector as the stock market opens tomorrow if UK inflation comes in hotter than expected.

Telecoms stocks were out of favour, with Vodafone and BT slipping over 1%.

Unilever v Reckitt Benckiser: Battle of the FTSE 100 consumer staple stalwarts

One may be forgiven for overlooking safer bets for their portfolio in the current climate.
Near-constant calls for economic deterioration and even recession have failed to materialise. Cyclical sectors have suffered and are of good value.
Nonetheless, Unilever and Reckitt Benckiser - two slow-moving, typically boring defensive stocks - are starting to look attractive compared to 2023 highs.
They have been integral to the FTSE 100’s recent declines, and long-term investors will be eyeing the FTSE 100 stalwarts at current valuations.
With bond proxy attributes, the companies have been shunned b...

Pelatro shares crash on payment disputes and funding woes

Pelatro is facing delays in collecting $1.1 million in outstanding payments from customers in Nepal, Myanmar and Bangladesh. The issues stem from government regulations in those countries requiring approval for payments to foreign companies. Two customers are also disputing $375,000 of the total owed.

Pelatro shares were down around 46% at the time of writing on Tuesday.

The company said the payment delays will impact their working capital but the board remains confident in eventually collecting amounts awaiting government approval.

Investors appear unwilling to hang around and wait for approvals as cash becomes tight for the customer engagement technology firm.

The payment delays, along with routine procedures, prompted Pelatro’s board to review all outstanding payments. The review uncovered unusual payment delays from four customers totaling $1.1 million of Pelatro’s $4.2 million in receivables.

Pelatro remains in discussions with the customers and expects to eventually collect the government-delayed payments. However, Pelatro has no clarity on timing as the payments require individual government approvals.

The company had $700,000 cash on hand at the end of June. Pelatro forecasts collecting $2.6 million from other customers through September. But based on assumptions and forecasts, Pelatro said they likely need external funding in the fourth quarter depending on timing of the outstanding payments.

The mention of external funding has sent investors running for the hills – understandable given the current market conditions.

EY confirms Darktrace accounts

0

Technology company Darktrace (LON: DARK) is the highest riser on the Main Market after a review of its accounts by EY. Management says that the results do not have any impact on previously filed accounts. The share price has risen 19% to 349.75p.

Darktrace joined the premium list on 4 May 2021, when it raised £143.4m at 250p/share. Cambridge-based Darktrace provides artificial intelligence (AI)-based cybersecurity services, and it was formed in 2013. The AI technology can detect and stop cyber attacks.

There were allegations about the figures of Darktrace and EY was allowed to all information and relevant people. The review was launched in February, and it covered partner channel contracts and marketing spend, appliance deployments and the process for calculating non-current deferred revenues. EY also reviewed the calculation of annual recurring revenues.

EY did uncover errors and inconsistencies in channel processes and controls. The Financial Conduct Authority and Financial Reporting Council have received copies of the review.

In the year to June 2023, revenues increased 31% to $544.3m. There was a 29% rise in annual recurring revenues. Revenues are expected to grow by between 22% and 23.5%.

The share price is 35% ahead this year, despite the allegations earlier in the year.

AIM movers: Arbuthnot Banking interest boost and CleanTech Lithium rally continues

1

A profit jump at Arbuthnot Banking (LON: ARBB) sparked a 17.7% rise in the share price to 1115p. The higher interest rates and focus on specialist lending are helping with the profit improvement. Credit risk is being tightened and loan growth has been slower than expected. Pre-tax profit improved from £3.4m to £26.4m, which is more than three-fifths of the full year forecast of £43m. Rises in deposit interest rates will catch up with lending rates in the second half. The interim dividend is raised from 17p/share to 19p/share.

Share prices of Cleantech Lithium (LON: CTL) and Ariana Resources (LON: AAU) continue to rise following announcements yesterday. Cleantech Lithium announced a 39% increase in measured and indicated resource for the Laguna Verde project. The resource is sufficient for an annual production rate of 20,000 tonnes of battery grade lithium carbonate for more than 30 years. The share price is 12.5% ahead at 45p. Ariana Resources revealed that the Slivova gold project in Kosovo has an updated measured and indicated resource of 1.1 million tonnes grading 4.1g/t gold and 15g/t silver plus a further 300,000 tonnes of inferred resources. The mineralisation is in the Main Gossan and Gossan Extension zones, with other areas still to be explored. The share price is 9.5% higher at 2.3p.

Alliance Pharma (LON: APH) edged up underlying interim revenues to £82.4m. Manufacturing delays due to regulatory issues hampered progress. Demand for scar treatment Kelo-Cote increased as destocking in China came to an end. Growth should accelerate in the second half. Nizoral revenues also grew strongly. Net debt decreased by £7.5m to £94.5m. Chief executive Peter Butterfield is back working full time. The share price increased 9.77% to 50p.

Medical imaging company Ixico (LON: IXI) is providing its services in a clinical trial of a novel therapeutic to treat the rare neurodegenerative disease Progressive Supranuclear Palsy. The contract is worth £1.3m over four years.  The share price rose 6.67% to 20p.

Pelatro (LON: PTRO) says a customer owing $550,000 will not be paying on time. There are other receivables which are delayed, and the total is $1.1m out of group receivables of $4.2m. For some customers this is due to waiting for government approval for payments to a foreign entity, but there are disputes with firms in Nepal and Myanmar that owe $375,000. There was $700,00 in the bank at the end of June 2023, but more finance is likely to be required before the end of the year. The share price slumped 45.6% to 4.35p.

United Oil & Gas (LON: UOG) says interim revenues declined from $9.8m to $6.4m. There have been difficulties getting cash out of Egypt. Two development wells came on stream in March and May respectively. Additional drilling starts in September. Quattro has still not paid for the interest in the Maria licence because it is still trying to raise the funds. There was cash of $550,000 at the end of June 2023. The share price dived 26.4% to 1.325p.

Mirriad Advertising (LON: MIRI) interim revenues from continuing operations improved by 26% to £576,000 as US revenues declined. Germany and the Middle East grew. There was cash of £9.8m at the end of June 2023. Second half revenues are usually double the interim level. The share price fell 13% to 1.175p.

Andrada Mining (LON: ATM) is raising £7.7m from an unsecured convertible loan note issue. This should provide sufficient finance for at least 15 months. The main asset is the Uis mine in Namibia. Construction of the lithium bulk sampling plant and tantalum production circuit has been completed and commissioning started. The share price is 4.7% lower at 6.9p.